+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Central Nervous Systems Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020

  • ID: 5205448
  • Report
  • November 2020
  • Region: Global
  • 39 pages
  • GlobalData

FEATURED COMPANIES

  • ARK Diagnostics Inc
  • Avacta Group Plc
  • ELITechGroup Inc
  • Nipro Europe N.V.
  • Pax Neuroscience Inc
  • Saladax Biomedical Inc
Summary

The publisher's Medical Devices sector report, “Central Nervous Systems Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Central Nervous Systems Therapeutic Drug Monitoring Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Central Nervous Systems Therapeutic Drug Monitoring tests are used for the measurement of drugs specific for central nervous system are covered under central nervous systems TDM.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Central Nervous Systems Therapeutic Drug Monitoring Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Central Nervous Systems Therapeutic Drug Monitoring Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Central Nervous Systems Therapeutic Drug Monitoring Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ARK Diagnostics Inc
  • Avacta Group Plc
  • ELITechGroup Inc
  • Nipro Europe N.V.
  • Pax Neuroscience Inc
  • Saladax Biomedical Inc
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Central Nervous Systems Therapeutic Drug Monitoring Overview

3 Products under Development
3.1 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
3.2 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Territory
3.3 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path

4 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products under Development by Companies
4.1 Central Nervous Systems Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
4.2 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development

5 Central Nervous Systems Therapeutic Drug Monitoring Companies and Product Overview

6 Central Nervous Systems Therapeutic Drug Monitoring- Recent Developments
6.1 Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities
6.2 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth - outlook confirmed
6.3 Jan 23, 2020: Avacta Group - Trading Update
6.4 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact

List of Tables
Table 1: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Table 2: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Territory
Table 3: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
Table 4: Central Nervous Systems Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
Table 5: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Table 6: ARK Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 7: ARK High Sensitivity Benzodiazepines Assay - Product Status
Table 8: ARK High Sensitivity Benzodiazepines Assay - Product Description
Table 9: ARK High Sensitivity Opiates Assay - Product Status
Table 10: ARK High Sensitivity Opiates Assay - Product Description
Table 11: ARK Perampanel Assay - Product Status
Table 12: ARK Perampanel Assay - Product Description
Table 13: ARK Tiagabine Assay - Product Status
Table 14: ARK Tiagabine Assay - Product Description
Table 15: ARK Zolpidem Assay - Product Status
Table 16: ARK Zolpidem Assay - Product Description
Table 17: ARK Zopiclone Assay - Product Status
Table 18: ARK Zopiclone Assay - Product Description
Table 19: Avacta Group Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Depression Test - Product Status
Table 21: Depression Test - Product Description
Table 22: Diagnostic Assay - Alzheimer's Disease - Product Status
Table 23: Diagnostic Assay - Alzheimer's Disease - Product Description
Table 24: Diagnostic Test - ADHD - Product Status
Table 25: Diagnostic Test - ADHD - Product Description
Table 26: Diagnostic Test - Bipolar Disorder - Product Status
Table 27: Diagnostic Test - Bipolar Disorder - Product Description
Table 28: Schizophrenia Response Test - Product Status
Table 29: Schizophrenia Response Test - Product Description
Table 30: ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Eon 100 Automated Chemistry Analyzer - Phenobarbital - Product Status
Table 32: Eon 100 Automated Chemistry Analyzer - Phenobarbital - Product Description
Table 33: Eon 100 Automated Chemistry Analyzer - Phenytoin Assay - Product Status
Table 34: Eon 100 Automated Chemistry Analyzer - Phenytoin Assay - Product Description
Table 35: Eon 300 Automated Chemistry Analyzer - Phenobarbital Assay - Product Status
Table 36: Eon 300 Automated Chemistry Analyzer - Phenobarbital Assay - Product Description
Table 37: Eon 300 Automated Chemistry Analyzer - Phenytoin Assay - Product Status
Table 38: Eon 300 Automated Chemistry Analyzer - Phenytoin Assay - Product Description
Table 39: Nipro Europe N.V. Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Lithium Assay - Product Status
Table 41: Lithium Assay - Product Description
Table 42: Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 43: VITROS XT 7600 Integrated System - Phenobarbital Assay - Product Status
Table 44: VITROS XT 7600 Integrated System - Phenobarbital Assay - Product Description

List of Figures
Figure 1: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Figure 2: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Territory
Note: Product cover images may vary from those shown
  • ARK Diagnostics Inc
  • Avacta Group Plc
  • ELITechGroup Inc
  • Nipro Europe N.V.
  • Ortho-Clinical Diagnostics Inc
  • Pax Neuroscience Inc
  • Saladax Biomedical Inc
  • Siemens Healthcare Diagnostics Inc
  • University of Colorado
Note: Product cover images may vary from those shown
Adroll
adroll